Abstract
The 4th European Breast Cancer Conference, organized under the auspices of the European Organization for Research and Treatment of Cancer Breast Cancer Group, of the European Breast Cancer Coalition (Europa Donna) and of the European Society of Mastology (EUSOMA), was held in Hamburg, Germany on 16–20 March 2004. The leading theme of the conference was partnership among scientists, clinicians, carers, advocates and patients. The present article provides a brief description of the most important conference presentations on molecular biology, epidemiology, prevention, pathology, diagnosis and treatment at all stages of breast cancer.
Highlights
The 4th European Breast Cancer Conference was held in Hamburg, Germany on 16–20 March 2004
The scientific program was initiated by Martine Piccart from Brussels, with her Emmanuel van der Schueren opening ceremony lecture on tailored adjuvant treatments of early breast cancer
The gene profiling technology based on microarray assays will hopefully allow for a better selection of candidates for systemic adjuvant treatment and for individualized chemotherapy
Summary
The 4th European Breast Cancer Conference was held in Hamburg, Germany on 16–20 March 2004. One of the conference highlights was a joint presentation of three recently published randomized trials addressing the role of aromatase inhibitors in the adjuvant treatment of early breast cancer: the Arimidex, Tamoxifen Alone or in Combination (ATAC) study (anastrozole versus tamoxifen versus combination administered for 5 years after local treatment ± chemotherapy), the MA17 study (5-year administration of letrozole versus placebo after 5 years of tamoxifen treatment), and the most recently published International Exemestane Study (exemestane versus tamoxifen for 2–3 years after 2–3 years of tamoxifen) [4,5,6].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
